Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH funds calcium research

This article was originally published in The Tan Sheet

Executive Summary

Two-year study evaluating whether calcium supplementation improves the health of overweight adults will enroll more than 300 participants by April 2003; 160 adults already have been recruited. Participants will be given either 1,500 mg calcium carbonate or placebo daily for two years; primary endpoints include improvements in body weight, cholesterol, blood pressure. Led by NIH principal investigator Shamik Parikh, MD, study is slated for completion in mid-2005 with funding from NICHD, ODS...

Two-year study evaluating whether calcium supplementation improves the health of overweight adults will enroll more than 300 participants by April 2003; 160 adults already have been recruited. Participants will be given either 1,500 mg calcium carbonate or placebo daily for two years; primary endpoints include improvements in body weight, cholesterol, blood pressure. Led by NIH principal investigator Shamik Parikh, MD, study is slated for completion in mid-2005 with funding from NICHD, ODS....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel